Novo Nordisk received positive feedback from CHMP for treating idiopathic short stature in children with the once-a-week medication Sogroya® in Europe.

Zhitongcaijing · 2d ago
Novo Nordisk received positive feedback from CHMP for treating idiopathic short stature in children with the once-a-week medication Sogroya® in Europe.